Please ensure Javascript is enabled for purposes of website accessibility

3 Unstoppable Stocks to Buy and Hold for Years

By David Jagielski – Jun 30, 2021 at 6:42AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

They are in industries where the annual growth rate is 10% or better.

Buying meme stocks or investing in a company due to a pandemic-related trend can be risky. Investors in these companies can face a lot of volatility, especially as consumer preferences or conditions in the economy change.

A better way to invest for the long term is by identifying trends that are likely going to continue or even intensify in the future. Robotic-assisted surgery, cloud-based technology, and sports betting are examples of sectors that could provide investors with some terrific growth opportunities for several years. And three companies that would give you exposure to those areas are Globus Medical (GMED -0.37%), Microsoft (MSFT -1.48%), and DraftKings (DKNG -3.46%)

Sports fans betting online by smartphone app sit together at a bar.

Image source: Getty Images

1. Globus Medical

Globus is a medical device company that makes surgical instruments and implantable devices. It also has an ExcelsiusGPS platform, which is a navigational system for robot-assisted surgery. The company says it is "the world's first revolutionary robotic navigation platform." It specifically helps with alignments of the spine.

The bulk of the company's revenue today comes from its musculoskeletal segment, which relates to its physical devices; in 2020, sales related to that segment totaled $748 million and represented 95% of its revenue. Its enabling technologies segment, which includes ExcelsiusGPS, generated a more modest $40.5 million in sales.

However, the growth opportunities in this area are too enticing to ignore. Analysts project that the market for robot-assisted surgical systems could be worth nearly $18 billion by 2027, growing at a compounded annual growth rate (CAGR) of 14.8% until then. 

With a solid business today that provides hospitals with important implantable devices plus an exciting growth area related to robotics, Globus can be an investment that provides excellent returns for many years. The healthcare stock has already been picking up steam in the past 12 months, rising more than 70% and outperforming the S&P 500, which is up just 42% during that period.

2. Microsoft

Tech giant Microsoft is an easy pick for long-term investors. The company provides businesses and individuals with many products and services that will be used for the foreseeable future. Its fastest-growing product is Azure, its cloud computing service where companies can build and test applications. Last quarter, for the first three months of 2021, its year-over-year growth rate was 50% -- highest among the company's segments.

The cloud computing market is a high-growth sector to invest in, which could be worth more than $832 billion in 2025. It is already more prevalent than robotic-assisted surgery, but it is still growing at a strong CAGR of 17.5%.

Microsoft also has a stable and growing business that is still generating great numbers. Its Office 365 suite, which includes popular programs like Word, Excel, and PowerPoint, grew its commercial sales by 22% in the most recent quarter. And because Office365 is a recurring service, it should be an excellent source of revenue for the company as businesses and individuals renew their licenses.

Now that companies are spending more time on the cloud, especially as employees look to continue working remotely, investing in businesses that have many attractive cloud-based products and services like Microsoft is a solid move. Shares of the tech stock are up 37% over the past year, and although they have underperformed the S&P 500, investors shouldn't count on that trend lasting over the long term. 

3. DraftKings

It has been more than three years since the U.S. Supreme Court lifted the federal ban on sports betting. It is a hot new sector to invest in, and it's only getting bigger as more states choose to legalize it.

Although not everyone has gotten on board with the industry, more than two dozen states now permit some form of sports betting. Globally, the market could be worth $134 billion by 2024 -- growing at a CAGR of close to 10%.

One company that is in an excellent position to benefit from that is DraftKings. It entered into an exclusive deal with ESPN last year, which will make DraftKings its "exclusive daily fantasy sports provider." While sports activity has been muted during the pandemic, as the economy gets back to normal and sports leagues are back to operating at or near capacity, it could lead to some stellar results for DraftKings this year. 

When the company released its latest results on May 7, it upgraded its guidance and now projects that sales could top $1.15 billion in 2021 (up from a previous forecast that called for no more than $1 billion in revenue). That represents a year-over-year growth rate of 79%. 

Sports betting should only become more popular in the years ahead as more states legalize it, leading DraftKings to deliver fantastic returns to investors. Over the past 12 months, the stock has risen by more than 55%, but that jump shouldn't scare away those with a long-term mindset.

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool's board of directors. David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Globus Medical and Microsoft. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Globus Medical, Inc. Stock Quote
Globus Medical, Inc.
GMED
$59.51 (-0.37%) $0.22
Microsoft Corporation Stock Quote
Microsoft Corporation
MSFT
$237.50 (-1.48%) $-3.57
DraftKings Inc. Stock Quote
DraftKings Inc.
DKNG
$15.33 (-3.46%) $0.55

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
342%
 
S&P 500 Returns
107%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.